प्रदाहक आन्त्र रोग (Hindi Wikipedia)

Analysis of information sources in references of the Wikipedia article "प्रदाहक आन्त्र रोग" in Hindi language version.

refsWebsite

Global rank Hindi rank

10nih.gov

4^th place

7^th place

8doi.org

2^nd place

5^th place

2web.archive.org

1^st place

2archive.org

6^th place

1ccfa.org

low place

1gaiagarden.com

low place

archive.org

पृष्ठ 152-156 (धारा: उत्तेजक आंत्र रोग (आईबीडी (IBD)) में:Elizabeth D Agabegi; Agabegi, Steven S. (2008). Step-Up to Medicine (Step-Up Series). Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-7817-7153-6.{{cite book}}: CS1 maint: multiple names: authors list (link)
Wright K, Rooney N, Feeney M; et al. (2005). "Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing". Gastroenterology. 129 (2): 437–53. डीओआई:10.1016/j.gastro.2005.05.026. पीएमआईडी 16083701. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)

ccfa.org

"Crohn's & Colitis Foundation of America". 27 जुलाई 2016 को मूल से पुरालेखित. अभिगमन तिथि: 15 जून 2020.

doi.org

Baumgart DC, Carding SR (2007). "Inflammatory bowel disease: cause and immunobiology". The Lancet. 369 (9573): 1627–40. डीओआई:10.1016/S0140-6736(07)60750-8. पीएमआईडी 17499605.
Baumgart DC, Sandborn WJ (2007). "Inflammatory bowel disease: clinical aspects and established and evolving therapies". The Lancet. 369 (9573): 1641–57. डीओआई:10.1016/S0140-6736(07)60751-X. पीएमआईडी 17499606.
Xavier RJ, Podolsky DK (2007). "Unravelling the pathogenesis of inflammatory bowel disease". Nature. 448 (7152): 427–34. डीओआई:10.1038/nature06005. पीएमआईडी 17653185.
Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV (2003). "Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease". Am. J. Gastroenterol. 98 (9): 2034–41. डीओआई:10.1111/j.1572-0241.2003.07660.x. पीएमआईडी 14499784.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Furrie E, Macfarlane S, Kennedy A; et al. (2005). "Synbiotic therapy ([[Bifidobacterium longum]]/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial". Gut. 54 (2): 242–9. डीओआई:10.1136/gut.2004.044834. पीएमसी 1774839. पीएमआईडी 15647189. {{cite journal}}: Explicit use of et al. in: |author= (help); URL–wikilink conflict (help)CS1 maint: multiple names: authors list (link)
Kruis W, Fric P, Pokrotnieks J; et al. (2004). "Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine". Gut. 53 (11): 1617–23. डीओआई:10.1136/gut.2003.037747. पीएमसी 1774300. पीएमआईडी 15479682. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Wright K, Rooney N, Feeney M; et al. (2005). "Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing". Gastroenterology. 129 (2): 437–53. डीओआई:10.1016/j.gastro.2005.05.026. पीएमआईडी 16083701. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Roifman I, Sun YC, Fedwick JP, Panaccione R, Buret AG, Liu H, Rostom A, Anderson TJ, Beck PL (2009). [linkinghub.elsevier.com/retrieve/pii/S1542-3565(08)01109-9 "Evidence of endothelial dysfunction in patients with inflammatory bowel disease"]. Clin. Gastroenterol. Hepatol. 7 (2): 175–82. डीओआई:10.1016/j.cgh.2008.10.021. पीएमआईडी 19121648. अभिगमन तिथि: 2009-11-04. {{cite journal}}: Check |url= value (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

gaiagarden.com

निचले आंत्र रोग के लिए एक फाइटोथेराप्युटिक दृष्टिकोण Archived 2011-07-11 at the वेबैक मशीन गैया गार्डन

nih.gov

pubmed.ncbi.nlm.nih.gov

Baumgart DC, Carding SR (2007). "Inflammatory bowel disease: cause and immunobiology". The Lancet. 369 (9573): 1627–40. डीओआई:10.1016/S0140-6736(07)60750-8. पीएमआईडी 17499605.
Baumgart DC, Sandborn WJ (2007). "Inflammatory bowel disease: clinical aspects and established and evolving therapies". The Lancet. 369 (9573): 1641–57. डीओआई:10.1016/S0140-6736(07)60751-X. पीएमआईडी 17499606.
Xavier RJ, Podolsky DK (2007). "Unravelling the pathogenesis of inflammatory bowel disease". Nature. 448 (7152): 427–34. डीओआई:10.1038/nature06005. पीएमआईडी 17653185.
Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV (2003). "Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease". Am. J. Gastroenterol. 98 (9): 2034–41. डीओआई:10.1111/j.1572-0241.2003.07660.x. पीएमआईडी 14499784.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Furrie E, Macfarlane S, Kennedy A; et al. (2005). "Synbiotic therapy ([[Bifidobacterium longum]]/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial". Gut. 54 (2): 242–9. डीओआई:10.1136/gut.2004.044834. पीएमसी 1774839. पीएमआईडी 15647189. {{cite journal}}: Explicit use of et al. in: |author= (help); URL–wikilink conflict (help)CS1 maint: multiple names: authors list (link)
Kruis W, Fric P, Pokrotnieks J; et al. (2004). "Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine". Gut. 53 (11): 1617–23. डीओआई:10.1136/gut.2003.037747. पीएमसी 1774300. पीएमआईडी 15479682. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Wright K, Rooney N, Feeney M; et al. (2005). "Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing". Gastroenterology. 129 (2): 437–53. डीओआई:10.1016/j.gastro.2005.05.026. पीएमआईडी 16083701. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Roifman I, Sun YC, Fedwick JP, Panaccione R, Buret AG, Liu H, Rostom A, Anderson TJ, Beck PL (2009). [linkinghub.elsevier.com/retrieve/pii/S1542-3565(08)01109-9 "Evidence of endothelial dysfunction in patients with inflammatory bowel disease"]. Clin. Gastroenterol. Hepatol. 7 (2): 175–82. डीओआई:10.1016/j.cgh.2008.10.021. पीएमआईडी 19121648. अभिगमन तिथि: 2009-11-04. {{cite journal}}: Check |url= value (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

ncbi.nlm.nih.gov

Furrie E, Macfarlane S, Kennedy A; et al. (2005). "Synbiotic therapy ([[Bifidobacterium longum]]/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial". Gut. 54 (2): 242–9. डीओआई:10.1136/gut.2004.044834. पीएमसी 1774839. पीएमआईडी 15647189. {{cite journal}}: Explicit use of et al. in: |author= (help); URL–wikilink conflict (help)CS1 maint: multiple names: authors list (link)
Kruis W, Fric P, Pokrotnieks J; et al. (2004). "Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine". Gut. 53 (11): 1617–23. डीओआई:10.1136/gut.2003.037747. पीएमसी 1774300. पीएमआईडी 15479682. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)

web.archive.org

"Crohn's & Colitis Foundation of America". 27 जुलाई 2016 को मूल से पुरालेखित. अभिगमन तिथि: 15 जून 2020.
निचले आंत्र रोग के लिए एक फाइटोथेराप्युटिक दृष्टिकोण Archived 2011-07-11 at the वेबैक मशीन गैया गार्डन